SWOT Analysis for Structure Therapeutics Inc - ADR

Positive Breakout Third Resistance ( LTP > R3)
Stocks whose current price is 20% higher than week low, and more than previous close
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Positive Breakout (LTP > R2)
Positive breakout third resistance ( LTP > R3)
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Positive Breakout (LTP > R1)
High Volume, High Gain
Top Gainers
Stock with Low PE (PE < = 10)
Volume Shockers
High Volume, High Gain

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Declining profits every quarter for the past 2 quarters
Stocks Underperforming their Industry Price Change in the Quarter